Cargando…
Bromocriptine mesylate: FDA-approved novel treatment for type-2 diabetes
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875741/ https://www.ncbi.nlm.nih.gov/pubmed/20523873 http://dx.doi.org/10.4103/0253-7613.56070 |